Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
06/2001
06/28/2001WO2001046220A2 Bioactive oligopeptides
06/28/2001WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer
06/28/2001WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
06/28/2001WO2001046125A2 Cd45 inhibitors
06/28/2001WO2001046121A2 Exciplexes
06/28/2001WO2001045678A2 Medicament, a method for its production and the use thereof
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
06/28/2001CA2395311A1 Exciplexes
06/28/2001CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
06/27/2001EP1109781A1 Process to continuously prepare an aqueous mixture of epsilon-caprolactam and epsilon-caprolactam precursors
06/27/2001EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF
06/27/2001EP0819113B1 Benzamides for neurodegenerative disorder treatment
06/27/2001EP0759066B1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof
06/27/2001EP0603403B2 Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound
06/27/2001CN1301131A Dipeptide apoptosis inhibitors and the use thereof
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6252078 Fungicides for the control of take-all disease of plants
06/26/2001US6252041 Depsipeptides containing non-natural amino acids
06/26/2001US6251918 For therapy of stroke, cerebral ischemia, head trauma, or epilepsy
06/26/2001US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/21/2001WO2001044226A1 Serine protease inhibitors
06/21/2001WO2001044218A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
06/21/2001WO2001044199A1 Compounds and compositions for delivering active agents
06/21/2001WO2001044190A1 Anthracene derivatives as anti-cancer agents
06/21/2001WO2001044170A1 Adamantane derivatives
06/21/2001WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
06/21/2001CA2395170A1 Anti-cancer agents (iii)
06/21/2001CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
06/21/2001CA2393711A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
06/20/2001EP1107997A2 Polymer production
06/20/2001EP1107944A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/20/2001EP0929515B1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
06/20/2001CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines
06/20/2001CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
06/19/2001US6248919 E.g., (2s)-2-(((5-((butyl(2-cyclohexylethyl)amino)methyl) -2'-methyl(1,1'-biphenyl)-2-yl)carbonyl)amino)-4-(methylsulfan yl)butanoic acid, or a pharmaceutically acceptable salt or prodrug thereof.
06/19/2001US6248894 Fungicides for the control of take-all disease of plants
06/19/2001US6248737 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects
06/19/2001US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
06/19/2001CA1341257C Benzhydrylamine derivatives
06/14/2001WO2001042195A1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties
06/14/2001WO2001042194A1 Adamantane derivatives
06/14/2001WO2001042173A2 Method for the preparation of enantiomerically enriched compounds
06/14/2001CA2394236A1 Adamantane derivatives
06/13/2001EP0888289B1 Anticonvulsant enantiomeric amino acid derivatives
06/13/2001EP0842143B1 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
06/13/2001EP0807101B1 2-aminoindans as selective dopamine d3 ligands
06/12/2001US6245937 Combinatorial libraries of chemical compounds synthesized by biphasic synthesis utilizing specified templates
06/12/2001US6245810 Amino acid derivatives
06/12/2001US6245359 Active agent transport systems
06/07/2001WO2001040148A2 Systems and methods to facilitate multiple order combinatorial chemical processes
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/07/2001US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant
06/07/2001US20010003001 Compounds and compositions for delivering active agents
06/07/2001DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation
06/07/2001CA2392919A1 Systems and methods to facilitate multiple order combinatorial chemical processes
06/06/2001CN1066713C Stilbene derivatives and pharmaceutical composition containing them
06/05/2001US6242615 Amidation of acid containing compounds; useful in inhibiting tumor necrosis factor and metalloproteinases
06/05/2001US6242495 Compounds and compositions for delivering active agents
06/05/2001US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents
06/05/2001US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation
06/05/2001US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
06/05/2001US6241968 Compositions for increasing the MRI contrast in visualizing the digestive tract of patients
05/2001
05/31/2001WO2000077032A3 Spermine:peptide-based surfactant compounds
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/30/2001EP1102744A1 Novel method for preparing optically active alpha-aminonitriles
05/30/2001EP1102743A1 Amide derivatives which are useful as cytokine inhibitors
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001CN1297432A Substd. amides, their production and their use
05/30/2001CN1296943A Process for preparing p-aminobenzoyl glutaminic acid by reducing p-nitrobenzoyl glutaminic acid
05/30/2001CN1066436C Cyclohexanes and cyclohexenes derivs.
05/29/2001US6239297 Sphingosine derivatives and medicinal composition
05/29/2001US6239074 Substituted 3-phenyluracils
05/25/2001WO2001036433A2 Synthetic lipid-a analogs and uses thereof
05/25/2001WO2001036404A1 Compounds and methods
05/25/2001WO2001036375A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
05/25/2001WO2000077027A3 Serine protease inhibitors
05/23/2001EP1100853A2 Adhesives and sealants
05/23/2001EP1100772A1 Open chain alkoxyamine compounds and their use as polymerization regulators
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP1100485A1 Substituted anilide compounds and methods
05/22/2001US6235912 Sphingosine analogues
05/17/2001WO2001034639A2 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS
05/17/2001WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001CA2388750A1 .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis
05/16/2001CN1295558A Novel local anesthetic compounds and uses
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/10/2001WO2001032691A1 Hcv ns3 protease inhibitors
05/10/2001WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
05/10/2001WO2001032604A1 Activators of soluble guanylate cyclase
05/10/2001WO2001032596A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents
05/10/2001WO2001032130A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
05/10/2001CA2390025A1 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
05/10/2001CA2389773A1 Activators of soluble guanylate cyclase
05/10/2001CA2389543A1 Hcv ns3 protease inhibitors
05/10/2001CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
05/09/2001EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments
05/09/2001EP0633776B1 Compounds useful for treating allergic and inflammatory diseases